Abstract: To describe reverse vaccinology, many people give it the wrong connotation. Genome information is used to begin the process of antigen discovery. Developing novel and effective vaccinations employs the genome that has been expressed. There has been a paradigm change in vaccine research, as shown by this finding (Tordelo, 2017). Using the genomes of pathogens as a source of knowledge, reverse vaccinology may be used to develop new vaccines.
[1]. Kwok, A. J., Mentzer, A., & Knight, J. C. (2021). Host genetics and infectious disease: new tools, insights, and translational opportunities. Nature Reviews Genetics, 22(3), 137–153. https://doi.org/10.1038/s41576-020-00297-6
[2]. Masignani, V., Pizza, M., & Moxon, E. R. (2019). The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology. Frontiers in Immunology, 10, 751. https://doi.org/10.3389/fimmu.2019.00751
[3]. Moxon, R., Reche, P., & Rappuoli, R. (2019). Frontiers in Immunology. Frontiersin.org. https://www.frontiersin.org/journals/immunology
[4]. Parioli, A., & Oxenius, A. (2021). Single B cell technologies for monoclonal antibody discovery. Trends in Immunology, 42(12), 1143–1158. https://doi.org/10.1016/j.it.2021.10.008
[5]. Pulendran, B., Arunachalam, P., & Hagan, D. (2021, April 6). Emerging Concepts in The Science of Vaccine Adjuvants. Https://Www.nature.com/Articles/S41573-021-00163-y. https://www.nature.com/articles/s41573-021-00163-y2021
[6]. Ramon, S., Conejero, Netea, Sancho, Palomares, & Subiza. (2018, December 17). Trained Immunity-Based Vaccine: A New Paradigm Shift for The Development of Broad-Spectrum Anti-Infectious Formulations. https://www.frontiersin.org/articles/10.3389/fimmu.2018.02936/full